The landscape of blood sugar treatment is evolving with the emergence of transdermal GLP-1 delivery . These convenient delivery systems offer a possibly more comfortable alternative to needle administrations for individuals managing diabetes 2. These patches deliver glucagon-like peptide-1 direct